DNER and leukemia: Winter et al. [60] created dBET1 by linking the BET inhibitor JQ1 with the thalidomide derivatives, which could induce the degradation of BRD4 protein in a human leukemia cell line AML, while the inactive dBET1 did not degrade the protein.